Clinical Trials

Breast Neoplasms

NCT03906669 2023-11-22

WinPro

200 enrolled

Breast Neoplasms

NCT05525481 2023-11-01

PREDICTAM

Phase 4 Unknown

100 enrolled

ER+ Breast Cancer

NCT01579734 2023-06-28

HOT

1,884 enrolled

Breast Neoplasms

NCT05801705 2023-05-18

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

700 enrolled

Hormone-receptor-positive Breast Cancer

NCT05800197 2023-04-06

NEMO

300 enrolled

Breast Neoplasms

NCT00412022 2023-03-24

HOBOE

1,294 enrolled

Breast Neoplasms

NCT02914158 2023-01-17

ASPAIT

680 enrolled

Breast Neoplasms

NCT05669768 2023-01-03

Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy

46 enrolled

Gynecologic

Ovarian Neoplasms

NCT05133674 2022-05-25

Therapeutic Dose Monitoring (TDM) of Tamoxifen

40 enrolled

Breast Neoplasms

NCT05016349 2021-08-23

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

160 enrolled

Breast Cancer Female

NCT04852081 2021-04-21

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

1,000 enrolled

Breast Neoplasms

NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

1,354 enrolled

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT01758146 2020-03-04

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

412 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT00541086 2020-02-07

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

3,697 enrolled

Breast Neoplasms

NCT04116827 2019-10-07

Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device

20 enrolled

Breast Neoplasms, Sleep Wake Disorders

NCT04046159 2019-08-06

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

810 enrolled

Carcinoma, Intraductal, Noninfiltrating

NCT04023292 2019-07-17

Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer

185 enrolled

Breast Neoplasms

NCT03582865 2019-07-08

Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen

100 enrolled

Breast Neoplasms

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

300 enrolled

Breast Cancer Organoids

NCT03137368 2018-10-31

STEP

300 enrolled

Breast Neoplasms

NCT03373708 2017-12-18

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Phase 2/3 Unknown

200 enrolled

Breast Diseases, Breast Neoplasms

NCT03351062 2017-11-22

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

844 enrolled

Breast Neoplasms

NCT03211572 2017-07-07

OTT 17-01

82 enrolled

Breast Neoplasms

NCT02513849 2017-05-09

Tamoxifen in Patients With Oesophageal Cancer

Phase 1 Unknown

20 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT02467686 2017-03-20

Cimicifuga

Phase 4 Unknown

60 enrolled

Sexuality

NCT02097459 2016-05-25

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

600 enrolled

Breast Neoplasms

NCT01503905 2016-05-24

Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

Phase NA Unknown

600 enrolled

Amenorrhea, Breast Neoplasms

NCT02482740 2015-06-26

TGOG1005

44 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02132000 2014-05-06

Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

Phase 2/3 Unknown

3,036 enrolled

Breast Cancer Patients in Premenopausal

NCT01622361 2013-09-30

NEST

290 enrolled

Breast Neoplasms

NCT00538330 2011-12-13

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

Phase NA Unknown

2,000 enrolled

Breast Neoplasms

NCT00973037 2009-09-09

ASTRRA-CYP2D6

922 enrolled

Breast Neoplasms

NCT00912548 2009-06-16

ASTRRA

1,234 enrolled